Summary of the TOPRA CEE Webinar: Regulatory Challenges in the CIS and Russia December 15, 2023

Summary of the TOPRA CEE Webinar: Regulatory Challenges in the CIS and Russia

On December 14, 2023, Inpharmatis experts participated in the webinar "Regulatory Challenges in the CIS and Russia" organised by TOPRA in CEE (Central Eastern Europe). During a two-hour discussion, webinar speaker Polina Dombure, CEO of Inpharmatis Group, and industry-leading experts reviewed actual regulatory issues in this strategically important region. 

The regulatory landscape of the pharmaceutical market in the CIS stands out as notably dynamic and intricate. The sector has faced significant regulatory challenges due to changes in global geopolitics. 

Having over 20 years of experience in the Life Sciences Industry in Europe and the CIS, Polina Dombure considered current requirements and trends in the Eurasian Economic Union (EAEU) and other countries. She described potential risks and outlined effective regulatory strategies in the region. 

There were Q&A sessions after each webinar topic. Region experts and heads of regulatory departments: Natalia Volovich (Gedeon Richter), Inga Klaus (Mayoly), Jelena Volperte (Olainfarm), and Natalia Starkova (Chiesi) answered questions. The exchange of experiences and practical knowledge provided webinar participants with a unique opportunity to communicate with industry leaders in regulatory affairs. 

The webinar attracted a significant number of engaged attendees, demonstrating the crucial role of participation in the pharmaceutical market in the CIS and Russia for businesses. Inpharmatis Group is going to continue to support the industry by providing expertise and solutions for pharmaceutical companies in the EAEU countries, Azerbaijan, Ukraine, Georgia, Moldova, Tajikistan, Turkmenistan, Uzbekistan, and Mongolia.